Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06511, USA.
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06511, USA; Department of Genetics, Yale University School of Medicine, New Haven, CT 06511, USA.
Cell Rep. 2018 Apr 24;23(4):1152-1165. doi: 10.1016/j.celrep.2018.03.043.
Pulmonary hypertension is a devastating disease characterized by excessive vascular muscularization. We previously demonstrated primed platelet-derived growth factor receptor β (PDGFR-β)/smooth muscle cell (SMC) marker progenitors at the muscular-unmuscular arteriole border in the normal lung, and in hypoxia-induced pulmonary hypertension, a single primed cell migrates distally and expands clonally, giving rise to most of the pathological smooth muscle coating of small arterioles. Little is known regarding the molecular mechanisms underlying this process. Herein, we show that primed cell expression of Kruppel-like factor 4 and hypoxia-inducible factor 1-α (HIF1-α) are required, respectively, for distal migration and smooth muscle expansion in a sequential manner. In addition, the HIF1-α/PDGF-B axis in endothelial cells non-cell autonomously regulates primed cell induction, proliferation, and differentiation. Finally, myeloid cells transdifferentiate into or fuse with distal arteriole SMCs during hypoxia, and Pdgfb deletion in myeloid cells attenuates pathological muscularization. Thus, primed cell autonomous and non-cell autonomous pathways are attractive therapeutic targets for pulmonary hypertension.
肺动脉高压是一种破坏性疾病,其特征是血管过度肌化。我们之前在正常肺的肌性-非肌性小动脉边界处,以及在缺氧诱导的肺动脉高压中,发现了被预先激活的血小板衍生生长因子受体β(PDGFR-β)/平滑肌细胞(SMC)标记祖细胞。在这个过程中,很少有关于分子机制的信息。本文中,我们发现预先激活的细胞中 Kruppel 样因子 4 和缺氧诱导因子 1-α(HIF1-α)的表达,分别需要以顺序的方式进行远端迁移和平滑肌扩张。此外,内皮细胞中的 HIF1-α/PDGF-B 轴非细胞自主地调节预先激活的细胞诱导、增殖和分化。最后,髓样细胞在缺氧时向远端小动脉 SMC 转分化或融合,髓样细胞中 Pdgfb 的缺失可减轻病理性肌化。因此,预先激活的细胞自主和非细胞自主途径是肺动脉高压有吸引力的治疗靶点。